Barry Delongchamps N, Schull A, Anract J, Abecassis JP, et al. Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial. PLoS One 2021;16:e0252040.
PMID: 34260598